ACOR - Acorda Therapeutics EPS misses by $0.10 misses on revenue May, 05 2020 04:02 PM Acorda Therapeutics Inc. Acorda Therapeutics (NASDAQ:ACOR): Q1 Non-GAAP EPS of -$0.51 misses by $0.10; GAAP EPS of -$0.14 beats by $0.31.More news on: Acorda Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...